Sept. 27, 2016
Brand Icon
- Qurgen announced the successful completion of a Pre-A round financing of US$4 million. This round was exclusively invested by Prowinner, a renowned investment institution. Thesuccessful financing signifies that Qurgen’s innovative technologies and industrialization potential in the global regenerative medicine sector have been highly recognized by the capital market.
- With the smooth completion of the Pre-A round financing, Qurgen will further accelerate its global R&D and industrialization layout, promote the early launch of innovative therapies, and contribute to the development of global public health.
